Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen
Changhu
C
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA. changhu.chen@ucdenver.edu
Damek
Denise
D
Gaspar
Laurie E
LE
Waziri
Allen
A
Lillehei
Kevin
K
Kleinschmidt-DeMasters
B K
BK
Robischon
Monica
M
Stuhr
Kelly
K
Rusthoven
Kyle E
KE
Kavanagh
Brian D
BD